Short-Form Ron Promotes Spontaneous Breast Cancer Metastasis through Interaction with Phosphoinositide 3-Kinase.
about
Pathogenesis of RON receptor tyrosine kinase in cancer cells: activation mechanism, functional crosstalk, and signaling addictionA novel RON splice variant lacking exon 2 activates the PI3K/AKT pathway via PTEN phosphorylation in colorectal carcinoma cells.RON is not a prognostic marker for resectable pancreatic cancer.Short-form RON overexpression augments benzyl isothiocyanate-induced apoptosis in human breast cancer cellsPreclinical Efficacy of Ron Kinase Inhibitors Alone and in Combination with PI3K Inhibitors for Treatment of sfRon-Expressing Breast Cancer Patient-Derived Xenografts.A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells.Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancerDietary chemopreventative benzyl isothiocyanate inhibits breast cancer stem cells in vitro and in vivo.Short-form Ron is a novel determinant of ovarian cancer initiation and progression.RON kinase isoforms demonstrate variable cell motility in normal cells.Characterization of RON protein isoforms in pancreatic cancer: implications for biology and therapeutics.The RON receptor tyrosine kinase promotes metastasis by triggering MBD4-dependent DNA methylation reprogramming.Recepteur d'origine nantais (RON), more than a kinase: Role in castrate-resistant prostate cancer.HRAS, EGFR, MET, and RON Genes Are Recurrently Activated by Provirus Insertion in Liver Tumors Induced by the Retrovirus Myeloblastosis-Associated Virus 2.The Tyrosine Kinome Dictates Breast Cancer Heterogeneity and Therapeutic Responsiveness.Role of Recepteur D'origine Nantais on Gastric Cancer Development and ProgressionTargeting PDK1 for Chemosensitization of Cancer Cells.RON Signaling Is a Key Mediator of Tumor Progression in Many Human Cancers.Inhibition of RON kinase potentiates anti-CTLA-4 immunotherapy to shrink breast tumors and prevent metastatic outgrowthmTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential
P2860
Q26864275-C51280F4-C676-42BF-B0A9-137C5509C2F1Q33889099-B6975F33-4918-4A5B-A4F9-E4B3BF930234Q34408923-1BB1C4C8-3F06-408D-84A0-FE44DDEAF621Q36132585-D0DAB897-3565-40C9-8CE3-CD75B4FB8701Q36377994-00A0839E-3C5C-46E2-89E5-14025B03A7E7Q36814075-A2725526-CFF6-4EC2-9C5D-EED913A66CE3Q36824455-1D9C5516-8A0B-402A-B0F0-7C5BD4319EEBQ37079634-E7FF9E43-B1F3-4103-B2A5-C68F94A1AF01Q37164553-CDD666D9-9452-48DC-A00A-15A7D2A81381Q37253779-241FEA8E-33EE-4417-BF28-DF06A814C5FEQ37564619-B534C78B-0D4C-442B-96A9-E75CA51DB503Q37645687-D1724BA4-7EEE-4269-BBA5-6927BD0C9CE2Q38543678-CA9449C7-8AD2-4026-875F-3BDAD929137FQ38645986-ED532C5A-976C-483F-8147-1C35C924C304Q38890318-40772B96-6B05-44E5-8818-9BAA90E10D23Q42262007-5EE55C32-5DDF-450F-BEC1-8C448A1D5335Q43276810-A2A2CED7-929A-4E13-8C17-D3D888A411DEQ53591553-44194106-779D-47C4-A94E-44DAF8D170F4Q56891079-964E02BF-9614-47EB-B874-759345CCE1B6Q59130211-BF5BBB94-667A-4CE6-8DA6-81E61B0A6258
P2860
Short-Form Ron Promotes Spontaneous Breast Cancer Metastasis through Interaction with Phosphoinositide 3-Kinase.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Short-Form Ron Promotes Sponta ...... ith Phosphoinositide 3-Kinase.
@ast
Short-Form Ron Promotes Sponta ...... ith Phosphoinositide 3-Kinase.
@en
type
label
Short-Form Ron Promotes Sponta ...... ith Phosphoinositide 3-Kinase.
@ast
Short-Form Ron Promotes Sponta ...... ith Phosphoinositide 3-Kinase.
@en
prefLabel
Short-Form Ron Promotes Sponta ...... ith Phosphoinositide 3-Kinase.
@ast
Short-Form Ron Promotes Sponta ...... ith Phosphoinositide 3-Kinase.
@en
P2093
P2860
P356
P1433
P1476
Short-Form Ron Promotes Sponta ...... ith Phosphoinositide 3-Kinase.
@en
P2093
Alana L Welm
Henok Eyob
Leigh Neumayer
Magdalena Bieniasz
Saundra S Buys
Xuemei Liu
Yi-Chun Lin
Yoko S Derose
P2860
P304
P356
10.1177/1947601911421924
P577
2011-07-01T00:00:00Z